首页> Metabolic brain disease> Correction to: Necrostatin-1?S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis

Correction to: Necrostatin-1?S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis

导出原文传递

翻译打印收藏纠错

第一作者： Kumari,Preeti

作者： Kumari,Preeti ^[1] ; Valencia,Fernandes ; Anika,Sood ; Islauddin,Khan ; Dharmendra Kumar,Khatri ; Shashi Bala,Singh

作者单位： Department of Pharmacology and Toxicology,National Institute of Pharmaceutical Education, and ^[1]

发布时间 2023-10-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Metabolic brain disease

2023年38卷6期

2193-2196页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Metabolic brain disease

2023年38卷6期

2193-2196页

检索历史清除

Correction to: Necrostatin-1?S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis

Metabolic brain disease

相似文献

同项目论文

Metabolic brain disease

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Correction to: Necrostatin-1?S mitigates type-2 diabetes-associated cognitive decrement and lipotoxicity-induced neuro-microglia changes through p-RIPK-RIPK3-p-MLKL axis

Metabolic brain disease

相似文献

同项目论文

Metabolic brain disease

相关期刊

检索历史清除